These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31478261)

  • 21. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
    Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
    BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
    Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
    Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-Regulation of HBXIP Inhibits Non-Small Cell Lung Cancer Growth and Enhances the Anti-Tumor Immunity of Mice by Reducing NRP-1.
    Wang L; Sun M; Lin X; Lei Y; Yin Z; Zhou W
    Ann Clin Lab Sci; 2021 Jul; 51(4):487-493. PubMed ID: 34452886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. XB130, regulated by miR-203, miR-219, and miR-4782-3p, mediates the proliferation and metastasis of non-small-cell lung cancer cells.
    Wang Q; Yang G; Jiang Y; Luo M; Li C; Zhao Y; Xie Y; Song K; Zhou J
    Mol Carcinog; 2020 May; 59(5):557-568. PubMed ID: 32159887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L; Cheng Y; Zou S; Song J
    Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL; Lin JC
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
    Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
    Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
    Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
    PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
    Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
    Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The GAUGAA Motif Is Responsible for the Binding between circSMARCA5 and SRSF1 and Related Downstream Effects on Glioblastoma Multiforme Cell Migration and Angiogenic Potential.
    Barbagallo D; Caponnetto A; Barbagallo C; Battaglia R; Mirabella F; Brex D; Stella M; Broggi G; Altieri R; Certo F; Caltabiano R; Barbagallo GMV; Anfuso CD; Lupo G; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.
    Martínez-Terroba E; Ezponda T; Bértolo C; Sainz C; Remírez A; Agorreta J; Garmendia I; Behrens C; Pio R; Wistuba II; Montuenga LM; Pajares MJ
    Lab Invest; 2018 Dec; 98(12):1562-1574. PubMed ID: 30181552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
    Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
    Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
    Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
    J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
    Han Y; Tian H; Chen P; Lin Q
    Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.